Hyundai Pharmaceutical Co., Ltd. logo

Hyundai Pharmaceutical Co., Ltd. (004310)

Market Closed
15 Jun, 06:30
KRX SM KRX SM
7,440. 00
+1,710
+29.8429%
155.25B Market Cap
- P/E Ratio
120% Div Yield
959,358 Volume
0 Eps
5,730
Previous Close
Add Transaction
Day Range
6,760 7,440
Year Range
3,380 15,960
Want to track 004310 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Hyundai Pharmaceutical Co., Ltd. (004310) Statistics

Valuation metrics

Market Cap 155.25B
Enterprise value 181.21B
Trailing P/E (ttm) 35.85
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 0.77
Price/Book (mrq) 1.11
Enterprise Value/Revenue 0.93
Enterprise Value/EBITDA 15.89

Overview

Shares outstanding 26.14M
Float 16.86M
Shares short -
% Held by insiders 0.32%
% Held by institutions 0%
Average volume (10 days) 247.96K
Average volume (90 days) 405.29K

Price summary

52-Week low 3,380
52-Week high 15,960
Beta 0.84
50-Day moving average 7,307.81
200-Day moving average 8,720.9

Dividends and splits

Forward annual dividend rate 120
Forward annual dividend yield 0.0164%
Trailing annual dividend rate 30
Trailing annual dividend yield 0.0052%
5-Year annual dividend yield 0.77%
Payout ratio 0.19
Dividend Date 3 Mar 2026
Ex-Dividend Date 3 Mar 2026
Last split factor 513:500
Last split Date 20 Oct 2017

Financials

Fiscal year

Fiscal year ends 30 Nov 2013
Most recent quarter (mrq) 28 Feb 2026

Profitability

Profit margin 0.02%
Operating margin 0.03%

Operational effectiveness

Return on assets 0.02%
Return on equity 0.04%

Income Statement

Revenue (ttm) 108.14B
Revenue per share (ttm) 7,446.52
Quarterly revenue growth (yoy) 0.05%
Gross profit (ttm) 40.49B
EBITDA 8.57B
Net income to common (ttm) 1.41B
Diluted EPS (ttm) 159.83
Quarterly earnings growth (yoy) 0.08%

Balance Sheet

Total cash (mrq) 14.63B
Total cash per share (mrq) 712.27
Total debt (mrq) 20.75B
Total Debt/Equity (mrq) 0.37
Current ratio (mrq) 1.28%
Book value per share (mrq) 5,143.92

Cash Flow

Cash flow statement 7.95B
Levered free cash flow (LFCF) 6.29B